SOPHiA GENETICS grants equity to president
SOPHiA GENETICS SA granted President Ross Muken equity-based compensation on April 2, 2026.
Rhea-AI Filing Summary
SOPHiA GENETICS SA granted President Ross Muken equity-based compensation on April 2, 2026. He received options to buy 628,743 ordinary shares at $5.04 per share, exercisable until April 2, 2036, and 431,211 restricted stock units that convert into ordinary shares as they vest.
According to the vesting terms, 25% of the RSUs vest on April 2, 2027, with the remaining 75% vesting in equal quarterly installments through April 2, 2030. The share options vest 25% on April 2, 2027, then in equal monthly installments through April 2, 2030, contingent on continued service.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 1,059,954 shares
Grant/Award
2 txns
Insider
Muken Ross
Role
President
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Share Option (Right to Buy) | 628,743 | $0.00 | $0.00 |
| Grant/Award | Ordinary Shares | 431,211 | $0.00 | $0.00 |
Holdings After Transaction:
Share Option (Right to Buy) — 628,743 contracts (Direct);
Ordinary Shares — 431,211 shares (Direct)
Footnotes (2)
- F1. Represents a restricted stock unit ("RSU") grant made under the Issuer's 2021 Equity Incentive Plan. Each RSU represents a contingent right to receive one ordinary share of the Issuer, subject to the Reporting Person's continued service with the Issuer through each applicable vesting date. 25% of the RSUs will vest on April 2, 2027, and the remaining 75% will vest in equal quarterly installments through April 2, 2030.
- F2. The share option vests and becomes exercisable as to 25% of the ordinary shares on April 2, 2027, and then in equal monthly installments through April 2, 2030.
Key Figures
Stock options granted: 628,743 options
Option exercise price: $5.04 per share
RSUs granted: 431,211 RSUs
+4 more
7 metrics
Stock options granted
628,743 options
Granted April 2, 2026 to President Ross Muken
Option exercise price
$5.04 per share
Exercise price for 628,743 options expiring April 2, 2036
RSUs granted
431,211 RSUs
Awarded under 2021 Equity Incentive Plan on April 2, 2026
RSU vesting start
25% on April 2, 2027
Initial vesting tranche for RSU grant
RSU remaining vesting
75% through April 2, 2030
Vests in equal quarterly installments
Option vesting
25% on April 2, 2027
Remainder vests in equal monthly installments to April 2, 2030
Option expiration
April 2, 2036
Expiration date for 628,743 share options
Key Terms
restricted stock unit ("RSU"), 2021 Equity Incentive Plan, vesting, share option, +1 more
5 terms
restricted stock unit ("RSU") financial
"Represents a restricted stock unit ("RSU") grant made under the Issuer's 2021 Equity Incentive Plan."
2021 Equity Incentive Plan financial
"Represents a restricted stock unit ("RSU") grant made under the Issuer's 2021 Equity Incentive Plan."
vesting financial
"25% of the RSUs will vest on April 2, 2027, and the remaining 75% will vest in equal quarterly installments"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
exercise price financial
"conversion_or_exercise_price": "5.0400""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did SOPHiA GENETICS (SOPH) report for Ross Muken?
SOPHiA GENETICS reported equity grants to President Ross Muken. He received options on 628,743 ordinary shares at $5.04 per share and 431,211 restricted stock units, all as compensation awards subject to vesting and continued service with the company over several years.
How many RSUs were granted to SOPHiA GENETICS President Ross Muken?
Ross Muken was granted 431,211 restricted stock units. Each RSU represents a contingent right to receive one ordinary share, with 25% vesting on April 2, 2027 and the remaining 75% vesting in equal quarterly installments through April 2, 2030, assuming continued service.
What are the terms of the stock options granted to Ross Muken at SOPHiA GENETICS?
Ross Muken received options on 628,743 ordinary shares at an exercise price of $5.04 per share. The options vest 25% on April 2, 2027, then in equal monthly installments through April 2, 2030, and expire on April 2, 2036, conditioned on continued service.
When do Ross Muken’s RSUs at SOPHiA GENETICS vest?
His RSUs vest over roughly three years. 25% of the 431,211 RSUs vest on April 2, 2027, while the remaining 75% vest in equal quarterly installments through April 2, 2030, provided he continues to serve at SOPHiA GENETICS during the vesting period.
Are Ross Muken’s equity awards at SOPHiA GENETICS open-market purchases?
No, these are compensation grants, not open-market purchases. The Form 4 shows awards of stock options and restricted stock units at a price of $0.00 per share, reflecting grants under the company’s 2021 Equity Incentive Plan rather than buys on the public market.
What plan governs the RSU grant to Ross Muken at SOPHiA GENETICS?
The RSU grant to Ross Muken was made under SOPHiA GENETICS’ 2021 Equity Incentive Plan. Each RSU represents a contingent right to receive one ordinary share, subject to vesting conditions and his continued service with the company through the specified vesting dates.
AI-generated analysis. How Rhea-AI works. Not financial advice.
